Cargando…
P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013703/ http://dx.doi.org/10.1016/S0960-9776(23)00377-6 |
_version_ | 1784906831755214848 |
---|---|
author | Mitova, V. Gavrilov, I. Gornev, R. Plachkova, M.D. Pakataridis, P. Atanasov, T. |
author_facet | Mitova, V. Gavrilov, I. Gornev, R. Plachkova, M.D. Pakataridis, P. Atanasov, T. |
author_sort | Mitova, V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10013703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100137032023-03-15 P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients Mitova, V. Gavrilov, I. Gornev, R. Plachkova, M.D. Pakataridis, P. Atanasov, T. Breast Poster Abstracts Elsevier Ltd. 2023-04 2023-03-14 /pmc/articles/PMC10013703/ http://dx.doi.org/10.1016/S0960-9776(23)00377-6 Text en Copyright © 2023 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Poster Abstracts Mitova, V. Gavrilov, I. Gornev, R. Plachkova, M.D. Pakataridis, P. Atanasov, T. P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title | P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title_full | P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title_fullStr | P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title_full_unstemmed | P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title_short | P259 Immune-mediated implications of SARS-CoV-2 in breast cancer patients |
title_sort | p259 immune-mediated implications of sars-cov-2 in breast cancer patients |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013703/ http://dx.doi.org/10.1016/S0960-9776(23)00377-6 |
work_keys_str_mv | AT mitovav p259immunemediatedimplicationsofsarscov2inbreastcancerpatients AT gavrilovi p259immunemediatedimplicationsofsarscov2inbreastcancerpatients AT gornevr p259immunemediatedimplicationsofsarscov2inbreastcancerpatients AT plachkovamd p259immunemediatedimplicationsofsarscov2inbreastcancerpatients AT pakataridisp p259immunemediatedimplicationsofsarscov2inbreastcancerpatients AT atanasovt p259immunemediatedimplicationsofsarscov2inbreastcancerpatients |